how glp-1 medications work Infographic Weight loss drugs – hope
Description
What has changed is that patients now have more options
It was reported that the weight loss property of most GLP-1 analogs, except for semaglutide administered subcutaneously once weekly of smoother pharmacokinetics, is hampered by the therapeutic window because of the dose-dependent side-effects 10,11
Large cardiovascular outcome trials have shown these medications provide cardiovascular protection rather than harm, with no identified thrombotic safety concerns from UK or European regulatory bodies
Always talk to your doctor about your health risks and needs before you start or stop any drug
H.BhutaniS.KimC
